PPD

It's time for another #WVCDC question of the day! Test your vaccine knowledge below.

📍 Washington, D.C. Find our team at booth 302 at #WorldVaccineCongress Washington. We have experts ready to chat, a fun trivia game (with an eco-friendly sling bag prize) and our popular chocolate truffle cookies! 🍪 #WVCDC

We're kicking off #WorldVaccineCongress Washington with a trivia challenge. If you're in D.C., swing by booth 302 for your chance to win an eco-friendly sling bag with our question of the day. If you can't join us at #WVCDC, you can still test your knowledge below. Come back tomorrow for the answer and a new trivia question.

Diabetic kidney disease (DKD) affects up to 40% of individuals with Type 2 diabetes and remains the leading cause of chronic kidney and end-stage renal disease worldwide. While recent therapeutic advances like SGLT2 inhibitors, finerenone and GLP-1 receptor agonists are transforming treatment, a critical challenge remains: ensuring clinical trials reflect the populations most impacted. With new FDA Diversity Action Plan requirements, the need for accurate, real-world demographic data has never been greater. Emerging insights from large-scale EHR datasets are helping bridge this gap, enabling more representative trial design and ultimately improving outcomes for patients. ▶ Read more on how data-driven approaches are advancing DKD research » http://spr.ly/6041B6Yaqt

Les Enterline, senior vice president and global head of PPD FSP solutions, joins Qualio's "From Lab to Launch" podcast to share how functional partnerships are evolving, strategies for today’s outsourcing challenges and his perspective on the future of clinical trial delivery. As trials grow more complex and internal teams are stretched, he emphasizes how a mixed model approach allows organizations to access specialized expertise while maintaining oversight, quality and operational control. 🎧 Listen to key insights from Les » http://spr.ly/6041B6g9NL

Science changes lives. For many of us, it’s also deeply personal. With more than 25 years in clinical research and a family impacted by Charcot-Marie-Tooth disease, Jenneen DeFiore's mission is clear: Accelerate progress for families still waiting. Through our Rare Disease & Pediatric Center of Excellence, we are partnering across the landscape to design trials that are both scientifically rigorous and deeply human, leveraging decentralized approaches to reach families wherever they are. Because every data point represents a life. ▶ Watch how we’re working together to bring therapies closer to those who need them most: http://spr.ly/6041B6e4BX

We believe in the promise of cell therapies to treat unmet medical needs. Our multidisciplinary team of experts has deep insights into the sophistication required to develop and execute a cell therapy study to the highest standards. Our full spectrum of services is designed to support sponsors at every stage of their clinical development journey, including both ex vivo approaches — cells collected and modified outside the body before reinfusion — and emerging in vivo strategies that engineer or direct immune cells within the patient. Learn more » http://spr.ly/6046B6dBca

Digital patient and clinician platforms are transforming how we design trials and deliver care, connecting lived experience with real-world clinical evidence to drive more meaningful outcomes. Learn how HealthUnlocked™ and PPD™ CorEvitas™ Clinical Registries are helping sponsors design more patient-centered studies and generate insights that better reflect real-world care. 📥» http://spr.ly/6047B6bUSW

There’s a lot of pressure on drug development teams right now, balancing speed, cost and complexity in an increasingly uncertain market. Our latest Pulse Report is a valuable read for anyone thinking about what comes next in pharma R&D. Based on insights from 150 global biotech and pharma leaders, it explores the real challenges shaping 2026, from regulation and AI to protocol complexity and strategic partnerships. 📊 Understand the trends and what they could mean for your organization and priorities in the year ahead. Read the report » http://spr.ly/6046B6w9OY

Our dermatology team is heading to Denver for #AAD2026! We’re proud to be attending the American Academy of Dermatology (AAD) Annual Meeting once again, and our experts in dermatology clinical research are looking forward to connecting with sponsors, partners and innovators. Will you be there? Scan the QR code to set up time to meet with the team at booth 1358. Learn more about our capabilities » http://spr.ly/6045B6nn2V